Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lethal-7d-3p microRNA (let-7d-3p) is a small, non-coding RNA molecule belonging to the highly conserved let-7 family, which is essential for regulating gene expression at the post-transcriptional level [1, 5]. It functions primarily by binding to the 3' untranslated regions (3' UTR) of target messenger RNAs, leading to their degradation or the inhibition of their translation into proteins [2, 12]. In many contexts, let-7d-3p acts as a tumor suppressor by targeting oncogenes such as KRAS, HMGA2, and C-MYC, and its downregulation is frequently observed in various cancers, including ovarian and cervical malignancies [1, 13]. Beyond oncology, let-7d-3p is involved in the pathophysiology of cardiovascular diseases like heart failure and inflammatory conditions such as sepsis, where it often serves as a circulating biomarker for diagnosis and prognosis [6, 7]. Therapeutic strategies targeting let-7d-3p include the use of miRNA mimics to restore its function in disease states or antisense oligonucleotides (antimiRs) to inhibit its activity when it is pathologically upregulated [2, 10]. However, the clinical application of these therapies faces challenges related to precise delivery and the potential for off-target effects due to the miRNA's ability to regulate multiple gene targets simultaneously [14, 15]. Its role in neurogenesis and mood disorders also suggests potential applications in psychiatric therapy [9].
Binds to the 3' untranslated region (3' UTR) of target mRNAs to induce translational repression or mRNA cleavage
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lethal-7d-3p microRNA (let-7d-3p).